Solifenacin Succinate

Product description

Solifenacin is an active substance for the treatment of overactive bladder. It is administered in the form of film-coated tablets.

Comprehensive documentation for drug registration of Solifenacin can be provided by Biesterfeld as referred.

CAS-No. Regulatory Monograph
242478-38-2 ASMF EP, USP

Tradename(s)

Solifenacin Succinate (Antimuscarinic)

Country availability

Available worldwide

Jan Knudsen

Contact person

Jan Knudsen

Sales


email   phone